Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Avid Bioservices (CDMO) PT Raised to $11 at H.C. Wainwright
September 11, 2018 7:12 AM EDTH.C. Wainwright analyst Joseph Pantginis raised the price target on Avid Bioservices (NASDAQ: CDMO) to $11.00 (from $6.00) while maintaining a Buy rating.
Pantginis commented, "Yesterday, CDMO reported F1Q19 results, posting EPS of ($0.06), compared with our estimate of ($0.01) and consensus of ($0.13). Revenue for the first quarter was $12.58 million compared with our estimate of $12.87 million and consensus of $8.96 million. Avid ended the quarter with $37.5 million in cash. Management reaffirmed its F2019 revenue guidance of $51-55 million. Under... More
Avid Bioservices (CDMO) Tops Q1 EPS by 3c
September 10, 2018 4:23 PM EDTAvid Bioservices (NASDAQ: CDMO) reported Q1 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.
... More